The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: First results of an open-label trial

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 5, 2004, Pages 365-369

  Tromm, A ^a   Niewerth, U ^b   Khoury, M ^c   Baestlein, E ^c   Wilhelms, G ^c   Schulze, J ^b   Stolte, M ^d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Ardeypharm GmbH   (Germany)

^c Mutaflor Collagenous Colitis S G ^*

^d INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Collagenous colitis; E. coli strain Nissle 1917; Therapy

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MUTAFLOR; PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGENOUS COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LAMINA PROPRIA; MALE; PATHOGENESIS; VIRUS STRAIN; YERSINIA;

COLITIS; COLLAGEN DISEASES; DEFECATION; DIARRHEA; DRUG LABELING; ESCHERICHIA COLI; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROBIOTICS; TREATMENT OUTCOME;

EID: 2642536920     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-812709     Document Type: Article

References (30)

1. Bohr J, Tysk C, Eriksson S et al. Collagenous colitis: A retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39: 846-851
2. Sylwestrowicz T, Kelly JK, Hwang WS et al. Collagenous colitis and microscopic colitis: the watery diarrhoea-colitis syndrome. Am J Gastroenterol 1989; 84: 763-768
3. Aigner T, Neureiter D, Müller S et al. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology 1997; 113: 136-143
4. Günther U, Herbst H, Matthes H et al. Deranges pattern of collagen synthesis and degradation in collagenous colitis. Gastroenterology 1997; 112 (S1): A365
5. Lazenby AJ, Yardley JH, Giardiello FM et al. Pitfalls in the diagnosis of collagenous colitis: experience with 75 cases from a registry of collagenous colitis at the Johns Hopkins Hospital. Hum Pathol 1990; 21: 905-910
6. Bohr J, Nordfelth R, Järnerot G et al. Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol 2003; 37: 711-714
7. Miehlke S, Schneider-Brachert W, Madisch A et al. High prevalence of Yersinia IgG and IgA in patients with collagenous colitis. Gastroenterology 2003; 124 (S1): A149
8. Schulze J, Sonnenborn U. The role of the gut flora in inflammatory bowel diseases. In: Shimoyama Tet al (Hrsg). Helicobacter meets inflammatory bowel disease. Tokyo: Medical Tribune, 2002: 393-417
9. Oelschläger TA, Altenhoefer A, Hacker J. Inhibition of Salmonella typhimurium invasion into intestinal cells by the probiotic E. coli straine Nissle 1917. Gastroenterology 2001; 120 (S1): A326
10. Boudeau J, Rich C, France CF et al. Escherichia coli strain Nissle 1917 inhibits adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli isolated from a Crohn's disease patient. Gastroenterology 2001; 120 (S1): A190
11. Kruis W, Schütz E, Fric P et al. Double-blind comparison of an oral Escherichia coli preparations and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 853-838
12. Kruis W, Fric P, Stolte M. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine, Gastroenterology 2001; 120 (S1): A127
13. Rembacken BJ, Snelling AM, Hawkey PM et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet 1999; 354: 635-639
14. Malchow HA. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterology 1997; 25: 653-658
15. Möllenbrink M, Bruckschen E. Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor). Med Klin 1994; 89: 587-593
16. Bruckschen E, Horosiewicz H. Chronische Obstipation. Vergleich von mikrobiologischer Therapie und Lactulose. MMW 1994; 136: 241-245
17. Fric P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003; 15: 313-315
18. Lindström CG. Collagenous colitis with watery diarrhoea - a new entity? Pathol Eur 1976; 11: 87-89
19. Bohr J, Olesen M, Tysk C et al. Collagenous and lymphocytic colitis: A clinical and histopathological review. Can J Gastroenterol 2000; 14: 943-947
20. Tremaine WJ. Collagenous colitis and lymphocytic colitis. J Clin Gastroenterol 2000; 30: 245-249
21. Fernandez-Banares F, Salas A, Esteve M et al. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term-follow-up. Am J Gastroenterol 2003; 98: 340-347
22. Zins BJ, Sandborn WJ, Tremaine WJ. Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol 1995; 90: 1394-1400
23. Fiedler LM, George J, Sachar DB et al. Treatment responses in collagenous colitis. Am J Gastroenterol 2001; 96: 818-821
24. Chande N, McDonald JWD, MacDonald JK. Interventions for treating collagenous colitis (Cochrane Review). The Cochrane Library 2003; 3: 1-27
25. Baert F, Schmit A, D'Haens G et al. Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122: 20-25
26. Bonderup OK, Hansen JB, Birket-Smith L et al. Budesonide treatment of collagenous colitis: A randomized, double blind, placebo controlled trial with morphometric analysis. Gut 2003; 52: 248-251
27. Miehlke S, Heymer P, Bethke B et al. Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002; 123: 978-984
28. Mäkinen M, Niemela S, Lehtola J et al. Collagenous colitis and Yersinia enterocolitica infection. Dig Dis Sci 1998; 43: 1341-1346
29. Sonnenborn U, Greinwald R. Beziehungen zwischen Wirtsorganismus und Darmflora. Stuttgart/New York: Schattauer Verlag, 1991
30. Altenhoefer A, Oswald S, Sonnenborn U et al. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med Microbiol 2004; 40: 223-229